Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2019

Single-cell receptor quantification of an in vitro coculture
angiogenesis model reveals VEGFR, NRP1, Tie2, and PDGFR
regulation and endothelial heterogeneity
Si Chen
Washington University in St. Louis

P. I. Imoukhuede
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Chen, Si and Imoukhuede, P. I., ,"Single-cell receptor quantification of an in vitro coculture angiogenesis
model reveals VEGFR, NRP1, Tie2, and PDGFR regulation and endothelial heterogeneity." Processes. 7,6.
356. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7978

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

processes
Article

Single-Cell Receptor Quantiﬁcation of an In Vitro
Coculture Angiogenesis Model Reveals VEGFR,
NRP1, Tie2, and PDGFR Regulation and
Endothelial Heterogeneity
Si Chen 1
1
2

*

and P. I. Imoukhuede 1,2, *

Department of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA; sic@wustl.edu
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana Champaign,
Urbana, IL 61801, USA
Correspondence: imoukhuede@wustl.edu

Received: 5 March 2019; Accepted: 5 June 2019; Published: 10 June 2019




Abstract: Angiogenesis, the formation of new blood vessels from pre-existing ones, is essential
for both normal development and numerous pathologies. Systems biology has oﬀered a unique
approach to study angiogenesis by proﬁling tyrosine kinase receptors (RTKs) that regulate angiogenic
processes and computationally modeling RTK signaling pathways. Historically, this systems biology
approach has been applied on ex vivo angiogenesis assays, however, these assays are diﬃcult to
quantify and limited in their potential of temporal analysis. In this study, we adopted a simple
two-dimensional angiogenesis assay comprised of human umbilical vein endothelial cells (HUVECs)
and human dermal ﬁbroblasts (HDFs) and examined temporal dynamics of a panel of six RTKs
and cell heterogeneity up to 17 days. We observed ~2700 VEGFR1 (vascular endothelial growth
factor receptor 1) per cell on 24-h-old cocultured HDF plasma membranes, which do not express
VEGFR when cultured alone. We observed 4000–8100 VEGFR2 per cell on cocultured HUVEC plasma
membranes throughout endothelial tube formation. We showed steady increase of platelet-derived
growth factor receptors (PDGFRs) on cocultured HDF plasma membranes, and more interestingly,
1900–2900 PDGFRβ per plasma membrane were found on HUVECs within the ﬁrst six hours of
coculturing. These quantitative ﬁndings will oﬀer us insights into molecular regulation during
angiogenesis and help assess in vitro tube formation models and their physiological relevance.
Keywords: angiogenesis; coculture; endothelial tube formation; ﬁbroblast; tyrosine kinase receptor;
VEGFR; PDGFR; Tie2; NRP; qFlow cytometry

1. Introduction
Angiogenesis, the sprouting and formation of new vessels from pre-existing vessels, is an essential
process of both normal development and numerous pathologies, including diabetic retinopathy, ischemia,
tumor growth, and metastasis. The principle cells involved are endothelial cells (ECs), which are the
primary cell structure of capillaries and form the lining of all other vessels. The angiogenic process includes
(1) stimulation of ECs by binding of angiogenic growth factors like vascular endothelial growth factor
(VEGF), to receptors on ECs; (2) EC invasion by production and release of proteases, which degrade the
extracellular matrix and basement membrane; (3) EC proliferation and migration; (4) EC differentiation
and tube formation; and (5) stabilization of newly formed blood vessels by pericyte [1,2].
In healthy tissue, this process is tightly regulated by a signaling network comprising pro- and
antiangiogenic growth factors, tyrosine kinase receptors (RTKs), extracellular matrix (ECM), and
neighboring cells. However, under pathologic conditions, such as cancer, the signaling network is
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altered to stimulate new blood vessels to sustain tumor growth, development, and metastasis. As such,
insights into signaling networks and how they transition between healthy and diseased states can
advance our understanding of complex biological processes such as angiogenesis.
To better understand angiogenesis, RTKs that regulate angiogenic processes have been extensively
proﬁled [3–8] and computationally modeled [9–12], some include: Vascular endothelial growth
factor receptors (VEGFRs) and their neuropilin (NRP) coreceptors, platelet-derived growth factor
receptors (PDGFRs), and Tie receptors. Computational models, based on mass-action kinetics of
the RTK signaling axis, have characterized VEGF–VEGFR binding in both healthy and diseased
tissue [13,14], VEGF spatial distribution in skeletal muscle [15–17], angiogenic sprouting in skeletal
muscle [18,19], and VEGF gradients in peripheral artery disease (PAD) [20]. A recent computational
model, which incorporated ex vivo VEGFR concentrations from breast cancer xenografts [4], has
successfully predicted that tumors having “high” concentrations of plasma membrane VEGFR1 could
be resistant to anti-VEGF drugs (angiogenesis inhibitors) [9,21]. Platelet-derived growth factor (PDGF)
models have also been developed, which examined PI3K and MAPK pathways in ﬁbroblasts [22,23].
This systems biology approach, which combines computational modeling and quantitative proﬁling of
the biological system, can oﬀer valuable insights; however, it is important to apply this approach on
physiologically relevant experimental models [24].
Historically, in vivo and ex vivo animal models have been the preferred method to study
these receptors and their roles in angiogenesis. However, these experimental models are limited
in their throughput, reproducibility, and potential of temporal analysis. Thus, advancement of
accurate angiogenesis models, in vitro, is paramount to further advancing our understanding of
angiogenesis regulation.
Over the past 20 years, various in vitro assays have been developed to study the angiogenesis
hallmarks, including: EC proliferation, migration, sprouting and tube formation, among others [25].
While these in vitro assays are robust, fast, and easy to perform, they are limited by how reﬂective the
assay is to the in vivo state. EC proliferation and migration assays are well-established [25,26], and can
be used for focused characterization of EC behavior, but only recapitulate certain phases of angiogenesis,
namely EC proliferation and migration, thus cannot reﬂect the complexity of angiogenesis in vivo.
Traditional Matrigel cord-forming or collagen I angiogenic invasion assays are used for evaluation of
tube formation, however, the tubes formed by Matrigel ECs are not physiologically accurate because
they have incomplete lumens [27]. A coculture assay of ﬁbroblasts and ECs developed by Bishop et al. is
another commonly used in vitro model for the evaluation of EC diﬀerentiation and tube formation [28].
Although the human umbilical vein endothelial cells (HUVEC)–human dermal ﬁbroblasts (HDF)
coculture is limited by the absence of pericyte biology, ﬁbroblasts serve a similar mural cell function
by secreting ECM components that support tube formation [29,30]. In addition, this coculture model
demonstrates its relevancy to in vivo angiogenesis: Morphological features of tubules formed in the
coculture assay more closely resemble capillaries in vivo than Matrigel tubes [27], and recapitulates
most phases of the angiogenic process, including EC proliferation, migration, diﬀerentiation, and tube
formation [31]. To examine how reﬂective the coculture model is to in vivo or ex vivo studies, it is
important to correlate the temporal dynamics of signaling network throughout tube formation with
in vivo or ex vivo characterizations.
Here, we demonstrate that a method combining our optimized RTK quantitative ﬂow (qFlow)
cytometry approach [3–5,7–9,32] and the HUVEC–HDF coculture model developed by Bishop et al.
presents opportunities to characterize temporal dynamics of several important signaling pathways
during angiogenesis. We start by optimizing the angiogenesis assay by coculturing HUVECs and
HDFs at diﬀerent seeding ratio, in diﬀerent media type and seeding order. To conﬁrm the growth of
EC tubes, we quantify several morphological characteristics. We monitor the concentration, cell-by-cell
distribution, and heterogeneity of a panel of key angiogenic receptors: VEGFR1, VEGFR2, Tie2, NRP1,
PDGFRα, and PDGFRβ throughout the tube formation. These quantitative data give insights into
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RTK regulation during angiogenesis and provide physiologically-relevant RTK concentrations for
computational models.
2. Materials and Methods
HUVEC–HDF coculture in microwell plates. According to previous reports by Bishop et al. [28],
HUVEC–HDF coculture were prepared by seeding mixtures of HDFs and HUVECs on polystyrene
cell culture surfaces. Fibroblasts secrete extracellular matrix proteins, as well as growth factors
such as VEGF and Ang-1, which are necessary for EC tube formation [33–36]. HDFs and HUVECs
were harvested from 80–90% conﬂuent monocultures before mixing and seeding for coculturing.
Monocultures of HDFs and HUVECs were cultured as previously described [37]. To determine the
optimized seeding ratio between these two cell types, we seeded mixtures of 1 × 104 HDFs and 1 × 104 ,
5 × 104 or 2 × 103 HUVECs in each well of a 24-microwell plate (BD Biosciences/Falcon, Heidelberg,
Germany) and cultured at 37 ◦ C, 5% CO2 in coculture media (see Media comparison). To determine
if seeding order has an eﬀect on the coculture assay, 1 × 104 HDFs were cultured at 37 ◦ C, 5% CO2 ,
in 200 μL Dulbecco’s modiﬁed eagle media (DMEM) with 4.5 g/L glucose, L-glutamine, and sodium
pyruvate (Cellgro, Corning, NY, USA), supplemented with 5% (v/v) fetal bovine serum (FBS, Thermo
Fisher Scientiﬁc, MA, USA) and 1% (v/v) penicillin/streptomycin (Thermo Fisher Scientiﬁc, MA, USA)
for 3 days, then media was removed and 5 × 104 HUVECs were seeded on top of HDFs in coculture
media [38].
Media comparison. In order to evaluate the eﬀect of diﬀerent media on tubule formation and key
angiogenic receptor levels, cocultures were maintained in two diﬀerent media: (1) Endothelial growth
media-2 (EGM-2, Lonza, IL, USA), and (2) DMEM with 4.5 g/L glucose, L-glutamine, and sodium
pyruvate (Cellgro, Corning, NY, USA), supplemented with 5% (v/v) FBS (Thermo Fisher Scientiﬁc, MA,
USA) and 1% (v/v) penicillin/streptomycin (Thermo Fisher Scientiﬁc, MA, USA). The 200 μL media was
added to each well of 24-microwell plate (BD Biosciences/Falcon, Heidelberg, Germany), and 12.5 mL
media was added for T75 ﬂasks. Media was routinely renewed every other day.
Immunoﬂuorescent imaging. Immunoﬂuorescent staining of ﬁbroblast–EC cocultures in 24-well
plates were performed according to an established protocol [27,28]. In brief, cocultures were ﬁxed
with ice-cold 4% paraformaldehyde (PFA) for 10 min and then incubated in 1% bovine serum albumin
(BSA, Fisher Scientiﬁc, Hanover Park, IL, USA), 0.3 M glycine (Sigma-Aldrich, St. Louis, MO,
USA) in PBST (phosphate-buﬀered saline (PBS) supplemented with 1% Tween 20) for 1 h at room
temperature. To diﬀerentiate HUVECs from HDFs, cocultures were labelled with 1:500 diluted
ﬂuorescein isothiocyanate (FITC)-conjugated mouse anti-human CD31 antibody (R&D, Minneapolis,
MN, USA) for 45 min at room temperature or overnight at 4 ◦ C. To identify cell nucleus, cocultures
were incubated with 1:1000 diluted DAPI (4 ,6-diamidino-2-phenylindole) for 5 min. After three PBS
washes, stained cocultures were stored at 4 ◦ C upon imaging. For angiogenesis analysis, four biological
replicates were cultured, and 2–4 images per well were taken with objectives 4× and 10× using a
FluoView® FV3000 confocal laser scanning microscope (Olympus, Inc., Tokyo, Japan). Each image was
captured at a resolution of 1024 × 1024 pixels (0.32 × 0.32 mm2 ). To optimize contrast and brightness,
images were processed using ImageJ software (Version 1.8.0, https://imagej.nih.gov/ij/index.html) prior
to angiogenesis analysis.
Angiogenesis analysis. Tubule networks were formed in cocultures. To characterize the growth
of tubule networks, several morphometric parameters of the network were obtained using the free
software AngioTool (Version 0.6a, https://ccrod.cancer.gov/conﬂuence/display/ROB2/Home) [39]. This
software is applied directly on processed images to extract quantitative information related to the
growth of tubule networks: tubule density (% tubules/total area), branching index (junctions/mm2 ),
and total tubule length. Tubule density measures the percentage of area occupied by tubules, thus
serves as a quantitative indicator of how dense tubules are. Branching points computes the number of
branch points per unit area, therefore provides a measure of angiogenic sprouting activity. Total tubule

Processes 2019, 7, 356

4 of 21

length returns the sum of Euclidean distances between the pixels of all the tubules in the image, hence
it provides a measure of the growth of tubules and branches.
HUVEC–HDF coculture in ﬂasks. Mixtures of 2 × 106 HUVECs and 2 × 106 HDFs were harvested
from 80–90% conﬂuent monocultures and seeded on to T75 ﬂasks (Corning, NY, USA). Cocultures
were maintained in HUVEC standard media, EGM-2, at 37 ◦ C, 5% CO2 up to 17 days. Media was
renewed every other day.
Coculture dissociation. After 24 h, 6 days, 11 days, or 17 days of culturing, EC-ﬁbroblast cocultures
were washed twice with 1× PBS, followed by 5–7-min incubation in CellStripperTM (Corning, NY,
USA) at 37 ◦ C. Lifted coculture tissues were transferred to a Petri dish, where Hank’s balanced salt
solution (HBSS) with 2 mM Ethylenediaminetetraacetic acid (EDTA, VWR, Chicago, IL, USA) and
0.2% BSA (Fisher Scientiﬁc, Hanover Park, IL, USA) was added to the tissues as they were minced
into 2 mm × 2 mm squares. Minced tissues were then incubated with 0.2% collagenase IV for 5 min
at 4 ◦ C. After the incubation, the collagenase-treated tissues were vortexed for 3–5 min with 1-min
interval to achieve optimal tissue dissociation. Dissociated tissues were then added bovine serum
albumin (BSA)-supplemented stain buﬀer [32], and ﬁltered through cell strainers (size 70 μm) to
ensure single-cell suspension. Cell suspensions were spun down at 500 ×g for 5 min, resuspended at
4 × 106 cells/mL in stain buﬀer, and then kept on ice until antibody staining.
Monoculture cell dissociation. We have previously shown that quantiﬁcation of plasma
membrane RTKs, including NRP1 and PDGFRβ, can be aﬀected by enzymatic cell dissociation
solution, such as TrypLETM (Thermo Fisher Scientiﬁc, MA, USA) [5,32]. To assess the eﬀect of the
coculture dissociation protocol, which includes a 5-min incubation with collagenase IV and some
rigorous mixing, we dissociated HUVEC and HDF monocultures using two methods: (1) The traditional
method where HUVECs and HDFs monocultures were lifted and dissociated using a nonenzymatic
dissociation buﬀer, CellStripperTM (Corning, NY, USA), as described previously [8,32]; (2) The coculture
dissociation mimicry where CellStripperTM -lifted cells were incubated with HBSS with 2 mM EDTA
(VWR, Chicago, IL, USA) and 0.2% BSA for 2–3 min, then with 0.2% collagenase IV for 5 min at
4 ◦ C, vortexed for 3–5 min with 1-min interval, ﬁltered through 70-μm cell strainers (Fisher Scientiﬁc,
Hanover Park, IL, USA ) and resuspended in ice-cold stain buﬀer at 4 × 106 cells/mL. qFlow cytometry
analysis showed insigniﬁcant diﬀerences of monoculture RTK concentrations between the coculture
dissociation method and the traditional method (Figure S2).
Plasma membrane receptor staining. 25 μL aliquots of cells (1 × 105 cells) were added to 5 mL
polystyrene round-bottom tubes (BD Biosciences, NJ, USA). FITC-anti-hCD31 (R&D, Minneapolis,
MN, USA) or APC-anti-hCD34 (R&D, Minneapolis, MN, USA) at recommended concentration by
their manufacturers were added to each sample tube to diﬀerentiate HUVECs from HDFs. Then,
phycoerythrin (PE)-conjugated monoclonal antibodies (R&D, Minneapolis, MN, USA) were added
at their respective concentrations: 14 μg/mL for VEGFR1 and VEGFR2, 7.1 μg/mL for NRP1 [5], and
9.4 μg/mL for PDGFRs. Sample tubes were protected from light and incubated for 40 min on ice. Cells
were washed, centrifuged at 500 ×g twice with 4 mL stain buﬀer, and resuspended in 300 μL stain
buﬀer. The precision and accuracy of qFlow cytometry proﬁling has been rigorously tested [37,40–42].
Quantitative ﬂow cytometry. Flow cytometry was performed on a LSR Fortessa ﬂow cytometer
(BD Biosciences, San Jose, CA, USA); BD FACSDIVATM software (Version 7.0, BD Biosciences, San Jose,
CA, USA) was used for data acquisition, and FlowJo (Version 10.5.3, Tree Star, Ashland, OR, USA)
software was used for data analysis. To distinguish between live and dead cells, 5 μg/mL Sytox Blue
(Thermo Fisher Scientiﬁc, MA, USA) was added to all samples. Tubes were vortexed immediately prior
to placement in the ﬂow cytometer. From each tube, 8000–10,000 live cells were collected. To subtract
cell autoﬂuorescence and background noise, one to two tubes of unlabeled cell samples were collected
as well. Sytox Blue was excited with a 403-nm violet laser, and PE was excited with a 561-nm blue laser.
Fluorescence of Sytox Blue was obtained with band ﬁlters at 450/50 nm, and ﬂuorescence of PE was
obtained with band ﬁlters at 582/15 nm. To help convert ﬂuorescence intensity to number of molecules,
Quantibrite PE beads (BD Biosciences, San Jose, CA, USA) [43,44] were collected and analyzed under

Processes 2019, 7, 356

5 of 21

the same compensation and voltage settings as cell ﬂuorescence data. Quantibrite PE beads comprise a
combination of polystyrene beads conjugated with diﬀerent density of PE molecules: Low (474 PE
molecules per bead), medium-low (5359 PE molecules per bead), medium-high (23,843 PE molecules
per bead), and high (62,336 PE molecules per bead).
Statistical analysis: Ensemble averages. Plasma membrane receptor concentration was calculated
using PE calibration standards as previously described [5,8,32]. Brieﬂy, a calibration curve that correlates
PE ﬂuorescence intensity with the number of PE molecules was determined by ﬁtting the geometric
mean of ﬂuorescence histograms of the aforementioned four PE bead populations to a linear regression:
y = mx + b, where x = log10 (Number of PE molecules per bead), y = log10 (PE geometric mean), where
m and b represented the slope and intercept of the linear regression, respectively. Ensemble average of
number of PE molecules per labeled cell, [PE], was calculated using the equation below:

[PE] = 10 m (log10 PElabeled
1

geometric mean−b)

− 10 m (log10 PEunlabeled
1

geometric mean−b)

Assuming one receptor-bound antibody was conjugated with one PE molecule, number of bound
receptors per cell was equal to number of PE molecules per cell.
Statistical analysis: Cell-by-cell analysis. A 2D histogram of receptor concentration within a cell
population was calculated using cell-by-cell PE fluorescence intensity as described previously [32]. Briefly,
we derived a signal-to-noise ratio by dividing the weighted integral of the labeled cell signal with the
unlabeled cell signal, and deriving the histogram of receptor concentration using this signal-to-noise ratio:



PE
/N
Hreceptor = Hsignal 1 −  unlabeled unlabeled
PElabeled /Nlabeled

(1)

where Hsignal is the histogram of PE ﬂuorescence from labeled cells, Hreceptor is the histogram of receptor
concentration, PElabeled and PEunlabeled are the ﬂuorescence signal from labeled cells and unlabeled cells,
respectively, and N is the number of cells in a dataset (contains two to three biological replicates).
The cell-by-cell analysis was performed using MATLAB software (Version 9.4.0, The MathWorks, Inc.,
Natick, MA, USA), and the cell-by-cell histograms were plotted using Origin software (Version 9.60,
OriginLab, Corp., Northampton, MA, USA).
Statistical analysis: Heterogeneity analysis. To examine cell heterogeneity based on each
receptors we examined, Bayesian information criterion (BIC)-assisted Gaussian mixture modeling was
performed to obtain number of subpopulations within each cell type from cocultures; quadratic entropy
(QE) was calculated for each receptor distribution as a quantitative measure of cell heterogeneity deﬁned
by receptor concentration [7]. In addition to BIC, we applied three criteria to exclude subpopulations
that are likely outliers or instrument and background noise: (1) Subpopulations with an average
receptor concentration higher than 107 receptors per cell are excluded, (2) subpopulations with a
density lower than 5% are excluded, and (3) all subpopulations with an average receptor concentration
lower than 600 receptors per cell are grouped together as one subpopulation. Studies have determined
that G proteins may number between hundreds of thousands and millions per cell [45,46], as such, cell
subpopulations with a higher than 107 receptors-per-cell concentration were considered outliers. We
found the cutoﬀ for nonspeciﬁc binding was ~600 PE molecules per cell previously, thus we considered
subpopulations with receptor concentration lower than 600 receptors per cell are nondiﬀerentiating.
3. Results
3.1. HUVEC–HDF Cocultures Formed Tubule Networks in a Two-Dimensional Environment
To establish a coculture assay, we adapted the HUVEC–HDF coculture model from Bishop et al. [28],
and assessed the following culturing conditions: Media, HUVEC:HDF seeding ratio, and seeding order.
When cultured alone, HUVECs and HDFs organized into typical cell monolayers (Figure S1a,e), whereas
they showed variability in cell behavior and organization when cultured together. Cocultures with 1:5
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HDFs-to-HUVECs seeding ratio formed tubules at day 17, and displayed HUVEC overgrowth regardless
of the seeding order, as observed by confluent patches of HUVECs, stained green with FITC-conjugated
CD31 antibody (Figure S1b,g). Cocultures with 1:1 HDFs-to-HUVECs seeding ratio (Figure S1c) presented
smaller EC clusters and more microvessel-like structures compared to 5:1 HDFs-to-HUVECs (Figure S1d).
HDFs were able to proliferate in DMEM supplemented with 10% FBS, however, DMEM media was not
able to support growth of HUVECs in cocultures, as observed by lack of HUVECs stained green and lack
of microvessel-like structures (Figure S1f,h). When HDFs were seeded three days before HUVECs, we did
not observe tubule structures up to 17 days in EGM-2 or DMEM (Figure S1g,h). As such, we established
that the following culturing logistics is optimal for having the most tubular structures and network within
17 days: HUVECs and HDFs seeded together at 1:1 ratio (3 × 104 cells/cm2 ) and cocultured in EGM-2. The
following characterization are performed using this optimal coculturing condition unless stated otherwise.
We observed morphological changes and the growth of tubule networks in cocultures up to 17 days.
After 24 h, HUVECs were seen dispersed in loosened clusters or single ECs with HDFs surrounded
(Figure S2). By day 6, HDFs grew confluent, while HUVECs organized into dense clusters (Figure 1A, left
panel, top). Microvessel-like structures were seen to originate from the HUVECs clusters. Between day 6 and
day 17, HUVECs continued to proliferate, migrate, and formed lengthened tubule structures and network,
which superficially resembled a capillary bed (Figure 1A, left panel, middle and bottom). To quantify the
growth of tubule network in cocultures, we measured tubule density, branching index, and total tubule
length using AngioTool software (Version 0.6a, https://ccrod.cancer.gov/confluence/display/ROB2/Home).
We showed significant increases in these morphometric parameters in day-11 and day-17 cocultures when
compared to the day-6 coculture (Figure 1B).

Figure 1. Analysis of angiogenesis in human umbilical vein endothelial cells (HUVEC)-human dermal
ﬁbroblasts (HDF) cocultures of 6, 11, and 17 days after seeding. (A) Representative images of day-6
(top), day-11 (middle), and day-17 (bottom) cocultures (left panel; green: Fluorescein isothiocyanate
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(FITC)-conjugated CD31 antibody), processed images with cell clusters cleared out and their skeletonized
images (middle panels), and a representative, enlarged part of the skeletonized images (right panel).
The vessels outlines are represented in yellow, the skeleton in red, and the branching points in blue.
Scale bar is 0.5 mm. (B) Graphical representations of the analysis with AngioTool performed on four
biological replicates and two to three images per replicate. Statistical analysis was by ANOVA test
(Tukey) *, p < 0.05; **, p < 0.01; ***, p < 0.001.

3.2. Co-Culturing Induced a Rapid Increase of VEGFR1 on HDFs within 24 Hours
VEGFRs are key regulators of angiogenesis, however, the exact role of VEGFR1 has been
controversial: VEGFR1 is conventionally described as a decoy receptor that does not produce
intracellular signals, due to its high VEGF aﬃnity but low phosphorylation compared to VEGFR2 [47],
however, emerging evidences suggest an active VEGFR1 signaling role [3,48,49]. As such, VEGFR1
quantiﬁcation can oﬀer insights into how VEGFR1 signaling supports vessel growth. We found that
HUVECs in cocultures presented fewer than 800 plasma membrane VEGFR1 per cell from the initial
HUVEC–HDF contact to 17 days of tubule development (Figure 2A). This concentration of VEGFR1 is
similar to its concentration on conﬂuent HUVEC monocultures that received the same procedure of cell
harvesting as cocultures (~600 VEGFR1 per cell) (ANOVA, p > 0.05). On the contrary, HDFs presented
high concentrations of plasma membrane VEGFR1 (~2700 receptors per cell) within 24 h in contact
with HUVECs (Figure 2A). By day 6, VEGFR1 concentration on HDF plasma membranes reduced
to below the detection limit of qFlow cytometry (~600 receptors per cell) [32] and remained below
the detection limit up to 17 days. To conﬁrm collagenase do not aﬀect plasma membrane receptor
concentrations, we compared receptor concentrations on collagenase-treated HUVECs and HDFs with
untreated cells, and found no signiﬁcant changes (Figure S3).

Figure 2. Quantification of angiogenic receptor concentrations on HUVECs and HDFs following 24-h,
6-day, 11-day, and 17-day coculturing. Dashed lines represent receptor concentrations of collagenase-treated
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monocultures when they reach 80–90% conﬂuency. Red: HUVECs; Blue: HDFs. Mean ± SEM of
receptor concentrations in cocultures were compared to monocultures and ANOVA Tukey test was
performed to determine the signiﬁcant diﬀerences (* indicates p < 0.05, ** indicates p < 0.01, and
*** indicates p < 0.001). VEGFR: Vascular endothelial growth factor receptor; PDGFR: Platelet-derived
growth factor receptor; NRP: Neuropilin.

Cell-by-cell analysis of both cocultured HUVECs and HDFs showed homogeneity in VEGFR1
throughout coculturing, as observed by Gaussian lognormal-shaped distributions (Figure 3A,D).
The rapid increase of VEGFR1 concentration in cocultured HDFs was reﬂected by a rightward shift
in the cell-by-cell distribution comparing to HDF monoculture (Figure 3D). To quantify the cell
heterogeneity within cocultures, we employed quadratic entropy (QE), which divides each cell-by-cell
distribution into 500 equally spaced bins, and then sums weighted diﬀerences of two bins based on
their means and distance between these two bins [50–52]. Thus, QE is a measure of cell heterogeneity
based on their plasma membrane RTK expression. We conﬁrmed the relatively low cell heterogeneity
in VEGFR1 concentration within a HUVEC–HDF coculture, as QE of both cell types remained below
0.45 up to 17 days (Figure 4A).

Figure 3. Cell-by-cell analysis of HUVEC–HDF coculture up to 17 days. We showed receptor
distributions of (A,D) VEGFR1, (B,E) VEGFR2, (C,F) Tie2, (G,J) NRP1, (H,K) PDGFRα, and (I,L)
PDGFRβ on HUVECs and HDFs from co-cultures and collagenase-treated monocultures.
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Figure 4. Quadratic entropy (QE) of co-cultured HUVECs and HDFs up to 17 days. We showed QE of
(A) VEGFR1, (B) VEGFR2, (C) Tie2, (D) NRP1, (E) PDGFRα, and (F) PDGFRβ on HUVECs and HDFs
from 24-h, 6-day, 11-day, and 17-day co-cultures. Dashed lines represent receptor concentrations of
collagenase-treated monocultures. Red: HUVECs; Blue: HDFs.

3.3. Cocultured HUVECs Showed Higher VEGFR2 Concentration than Monoculture throughout
Tubule Development
VEGF–VEGFR2 signaling is widely studied, because this signaling is considered to be
proangiogenic [53,54]. In line with a VEGFR2 proangiogenic role, we observed signiﬁcantly higher
plasma membrane VEGFR2 concentrations on cocultured HUVECs (4300–8100 receptors per cell)
compared to conﬂuent HUVEC monocultures (3300 receptors per cell) (Figure 2B). HDF plasma
membranes express low to no VEGFR2s when cocultured alone; similarly, cocultured HDFs had low
plasma membrane VEGFR2 (390–1100 receptors per cell) throughout the 17 days of tubule development
(Figure 2B).
Cell-by-cell analysis suggest subpopulations of varying VEGFR2 concentration among cocultured
HUVECs (Figure 3B). This high cell heterogeneity in VEGFR2 plasma membrane concentration was
also captured by QE, as QE of 24-h VEGFR2 was approximately two-fold higher than day 6–17
(Figure 4B). The subpopulations within VEGFR2 cell-by-cell distribution and their characteristics were
further determined by Gaussian mixture modeling [4,9], a method we employed to identify log-normal
subpopulations described by their mean, standard deviation, and density. Particularly, BIC-assisted
Gaussian mixture model showed 25% of the HUVECs from 24-h cocultures had 3100 plasma membrane
VEGFR2 per cell on average, 46% had an average of 8400 plasma membrane VEGFR2s per cell, and 29%
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had an average of 17,000 plasma membrane VEGFR2 per cell (Figure 5A). Furthermore, BIC-assisted
Gaussian mixture model showed 9% of the HUVECs from day-11 cocultures had 4700 plasma membrane
VEGFR2 per cell on average, while 91% had an average of 7300 plasma membrane VEGFR2 per cell
(Figure 5B). This HUVEC heterogeneity represented by subpopulations on day 11 was not captured by
QE, which was as low as 0.23 (Figure 4B). In contrast, cell-by-cell analysis showed that the majority of
HDFs were below 1000 plasma membrane VEGFR2 per cell for both HDF monoculture and cocultured
HDFs (Figure 3E). These quantitative results showed that VEGFR2 signaling played an active role in
angiogenic ECs throughout tubule formation.

Figure 5. Bayesian information criterion (BIC)-assisted Gaussian mixture modeling identiﬁes
subpopulations within mixtures. (A) The 24-h cocultured HUVECs have three subpopulations
expressing 3100 VEGFR2 per cell, 8400 VEGFR2 per cell, and 17,000 VEGFR2 per cell on their plasma
membranes. (B) Day-11 cocultured HUVECs have two subpopulations expressing 4700 plasma
membrane VEGFR2 per cell and 7300 plasma membrane VEGFR2 per cell. (C) Day-17 cocultured
HUVECs have two subpopulations expressing 9,000 plasma membrane NRP1 per cell and 49,300 plasma
membrane NRP1 per cell. (D) Day-6 cocultured HDFs have two subpopulations expressing 5500 plasma
membrane NRP1 per cell and 58,500 plasma membrane NRP1 per cell. (E) Day-17 cocultured HUVECs
have two subpopulations expressing 700 and 8800 plasma membrane PDGFRβ per cell.
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3.4. Tie2 Concentrations on Cocultured HUVECs are Similar to Monocultures
Tie2 maintains the vascular integrity of mature vessels and is thought to mediate quiescence of
blood vessels through angiopoietin (Ang)–Tie2 signaling [55]. Although the ensemble average did not
reveal signiﬁcant changes in plasma membrane Tie2 concentrations through 24 h to 17 days of tubule
development (1500–2300 Tie2 per cell), when compared to conﬂuent HUVEC monocultures (2100 Tie2
per cell), ensemble averages showed a 50% increase in plasma membrane Tie2 concentration from
day 11 to day 17 (Figure 2C). This increase in Tie2 concentration was reﬂected by a rightward shift of
cell-by-cell analysis on day 17 when compared to cocultures at earlier stages (Figure 3C). In contrast,
cell-by-cell analysis of HDFs showed that most HDFs, monocultured and cocultured, expressed little
to no Tie2 on their plasma membranes (Figure 3F). Cocultured HUVECs showed homogeneity of Tie2
concentration across cells according to cell-by-cell analysis, and the low heterogeneity is conﬁrmed by
a relatively low QE, which remained lower than 0.4 throughout tubule formation (Figure 4C).
3.5. NRP1 Concentration Decreased on Cocultured Cells within 11 Days
NRP1, a VEGFR coreceptor, is highly expressed on both ECs and ﬁbroblasts, where we have
measured 35,000–73,000 plasma membrane NRP1 per EC and 70,000–120,500 plasma membrane NRP1
per ﬁbroblast in vitro [5,8]. We observed a downregulation of NRP1 on cocultured HUVECs from
the initial HUVEC–HDF contacts to day 11 (Figure 2D). Quantitatively, plasma membrane NRP1
concentration on cocultured HUVECs decreased from 47,000 receptors per cell to 28,900 receptors per
cell after 11 days, and remained steady until day 17. However, we did not observe any signiﬁcant
diﬀerence in plasma membrane NRP1 concentration between HUVEC monocultures and cocultures.
In contrast, cocultured HDFs present signiﬁcantly lower number of NRP1s on their plasma membranes
throughout tubule development when compared to monocultures (p < 0.001, Figure 2D). Throughout
tubule development, plasma membrane NRP1 concentration on cocultured HDFs decreased from
73,300 receptors per cell to 52,400 receptors per cell within 6 days, and bounced back to 77,800 receptors
per cell on day 17.
Cell-by-cell analysis of NRP1 concentration revealed high heterogeneity among cocultured
HUVECs on day 17 (Figure 3G), which was conﬁrmed by a high QE of 0.6 (Figure 4D). BIC-assisted
Gaussian mixture model identiﬁed a low-NRP1 subpopulation (9000 NRP1 per cell, 67%) and
a high-NRP1 subpopulation (49,300 NRP1 per cell, 29%) within cocultured HUVECs on day 17
(Figure 5C). For cocultured HDFs, cell-by-cell analysis conﬁrmed the changes in NRP1 plasma
membrane concentration by a right-shifted distribution (Figure 3J), while QE remained lower than 0.35
except for day 6 (Figure 4D). In contrast, cocultured HDFs showed low heterogeneity in NRP1 plasma
membrane concentrations, as observed by the Gaussian lognormal-shaped distributions (Figure 3J).
QE for cocultured HDFs remained similar to or lower than monocultured HDFs except for day 6,
suggesting subpopulations (Figure 4D). A further analysis of cocultured HDFs on day 6 revealed a
low-NRP1 subpopulation (5500 NRP1 per cell, 12%) and a high-NRP1 subpopulation (58,500 NRP1 per
cell, 88%) using a two-component mixture model (Figure 5D).
3.6. PDGFRα and PDGFRβ Showed a Steady Increase on Cocultured HDFs from Day 6
PDGFRs, typically expressed by perivascular cells including pericytes and ﬁbroblasts, serve
important roles in supporting vasculature and tissue repair [8,34,35,56,57]. We have previously
quantiﬁed 4600 plasma membrane PDGFRα per cell and 93,300 plasma membrane PDGFRβ per cell on
conﬂuent HDF monoculture, and how growth factors regulate PDGFRs [8]. While plasma membrane
PDGFRα concentration on cocultured HDFs remained two- to six-fold lower than monocultured HDFs,
we observed a steady increase of plasma membrane PDGFRα from 1,000 receptors per cell on day 6 to
4500 receptors per cell on day 17 (Figure 2E). Similarly, as tubules started to form on day 6, PDGFRβ
plasma membrane concentration increased from 34,800 receptors per cell to 103,300 receptors per
cell on day 17 (Figure 2F). Cell-by-cell analysis of cocultured HDFs conﬁrmed this increase in both
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PDGF receptors throughout tubule development (Figure 3K,L). HDF heterogeneity in PDGFR plasma
membrane concentrations was relatively low according to the cell-by-cell analysis, which is conﬁrmed
by a QE lower than 0.5 for both PDGFRα and PDGFRβ (Figure 4E,F).
3.7. PDGFRβ Observed on Cocultured HUVECs but Not PDGFRα
Almost most macrovascular ECs do not natively express PDGFRs [32,58,59], however, multiple
studies have reported PDGFR expression on ECs undergoing angiogenesis [60–62]. Aligned with these
ﬁndings, we observed low to no PDGFRβ plasma membrane expression on HUVEC monocultures,
and consistent PDGFRβ expression (~600–2900 PDGFRβ per cell) on cocultured HUVECs throughout
tubule development (Figure 2F). In contrast to the steady increase of PDGFRs on HDFs from day 6 to day
17, PDGFRβ plasma membrane concentration on HUVECs were higher during the initial HUVEC–HDF
contacts (1900 PDGFRβ per HUVEC after 24 h) and cluster formation (2900 PDGFRβ per HUVEC on
day 6), but decreased as tubules develop. Cell-by-cell analysis conﬁrmed the increase in PDGFRβ
plasma membrane concentration by day 6, evidenced by a rightward shift of cell-by-cell distribution
(Figure 3I). Although ensemble average of PDGFRβ plasma membrane concentration was low on day
17, high-PDGFRβ subpopulation was observed among cocultured HUVECs. A two-component mixture
model determined a low-PDGFRβ subpopulation (700 receptors per cell, 90%) and a high-PDGFRβ
subpopulation (8800 receptors per cell, 10%) within cocultured HUVECs on day 17 (Figure 5E). This
heterogeneity was also captured by a high QE of 0.55 as well as a two-fold increase from day 11 to day
17 (Figure 4F). These quantitative ﬁndings showed HUVECs, when interacting with ﬁbroblasts, may
express transmembrane PDGF receptors.
In contrast to the consistent PDGFRβ expression on cocultured HUVECs, we found little to no
plasma membrane PDGFRα up to 17 days (Figure 2E). Cell-by-cell distributions showed HUVEC
heterogeneity in PDGFRα plasma membrane concentrations (Figure 3H), along with a QE higher than
0.3 (Figure 4E). However, this heterogeneity can be due to background noise and nonspeciﬁc antibody
binding since the receptor concentration is below the measuring limit of qFlow cytometry [32].
4. Discussion
The study of angiogenesis can be advanced when we apply systems biology, the approach
combining computational models and quantitative characterization of biological organisms, on
experimental models that reﬂect in vivo systems. However, assessing how in-vivo-like a model is
has long been a challenge in the ﬁeld of angiogenesis [25]. While characterizing morphological
features like tube length and network is essential, it is important to incorporate morphological
characterization with molecular proﬁling when assessing the suitability of an in vitro model. This
study proposes that proﬁling temporal dynamics of angiogenic RTKs on single cell membranes during
an angiogenesis assay can give us insights into how closely it reﬂects the in vivo state. We adopted a
two-dimensional (2D) HUVEC–HDF coculture assay and measured single-cell RTK concentrations
and cell-to-cell heterogeneity as endothelial tubule networks form. We found that the initial contact of
HUVECs and HDFs induced an increase of VEGFR1 on HDF plasma membranes within 24 h, whereas
monocultured HDFs expressed low to no VEGFRs on their plasma membranes. VEGFR1 on cocultured
HUVECs remained a similar concentration as HUVEC monocultures throughout tubule development,
whereas VEGFR2 remained a relatively high concentration, suggesting diﬀerent roles they play during
angiogenesis. We observed a ~50% increase in Tie2 concentration on HUVECs during late-stage tube
formation, which aligns with the role of Ang–Tie2 signaling mediating quiescence of blood vessels.
PDGFRs showed a steady increase on cocultured HDFs from day 6 to day 17, indicating an active
role of PDGFRs as ﬁbroblasts support tubule development. Further, we observed PDGFRβ but not
PDGFRα on cocultured HUVECs as tubules develop, suggesting diﬀerent roles PDGFRα and PDGFRβ
may play during angiogenesis. In following paragraphs, we will discuss these key ﬁndings in detail
and compare them with proﬁles of angiogenic receptors we found in literatures.

Processes 2019, 7, 356

13 of 21

The HUVEC–HDF coculture model we adopted from Bishop et al. [28] has several advantages
over EC monocultures. Traditionally, EC monocultures in vitro have been used in angiogenesis
assays including EC proliferation assays, migration assays, and tube formation assays. Although
EC-only models have some advantages in studying certain EC-speciﬁc elements, the multicellular
processes of angiogenesis call for a more complex experimental model. Indeed, one study found that
the morphology of tubules formed in coculture assays were signiﬁcantly more heterogeneous and
more closely resembled capillaries in vivo than Matrigel tubules [27]. In another study, pericytes-EC
cocultures showed much narrower and elongated EC tubes compared to EC-only tubes which grow
wider and less elongated with time [25,63]. The pairing of ECs and ﬁbroblasts may be the ideal
choice for a simple 2D model without adding complex proteins or ECM components. We observed
microvessel-like structures, surrounded by ﬁbroblasts, emerged from EC plagues, and lengthened
to form a network by day 17 (Figure S1c); while HUVECs by themselves cultured on a 2D ﬂask did
not form tubules (Figure S1a), which is consistent with previous studies that cocultured ECs with
ﬁbroblasts [28,64]. It makes sense because ﬁbroblasts secret angiogenic factors, such as VEGF and
Ang-1, as well as ECM proteins, which are necessary for EC sprouting [33–36]. One study found
that ECs failed to form tubules on smooth muscle cells [64]. Bishop et al. also reported that direct
admixture of smooth muscle cells or pericytes with ECs failed to induce tubule formation, likely due to
the insuﬃcient amount of ECM components being produced [28]. While pericyte-EC cocultures are
more close to capillaries in vivo, ﬁbroblasts may produce more ECM proteins, are easier to obtain and
purify than pericytes [65,66], and they express some pericyte markers like PDGFRβ [8,66]. A more
in-vivo-like angiogenesis model may be a multiculture with three cell types: ECs which are the main
component of vessels, ﬁbroblasts which provide ECM components and growth factors, and pericytes
which wrap around vessels and stabilize vessel growth.
The average of ~2700 VEGFR1s per cocultured HDF within 24 h, represents a signiﬁcant number
of VEGFRs, given that HDFs show low to no VEGFR1 when cultured alone [8]. This cannot be
contamination from HUVECs, because cell-by-cell analysis of VEGFR1 on cocultured HUVECs shows
no subpopulations having higher VEGFR1 concentration that might overlap with VEGFR1–HDF
cell-by-cell histogram (Figure 3A,D). The high-VEGFR1 and low-VEGFR2 levels we observe on
cocultured HDF plasma membranes after 24 h correlate with previous ex vivo studies showing
high-VEGFR1 (36,000 VEGFR1s per cell) and low-VEGFR2 levels on BALB/c derived mouse
ﬁbroblasts [6], while the high-VEGFR1 surface-level diﬀers from HDF monoculture and NIH3T3s, both
of which do not natively express VEGFR1 or VEGFR2 in vitro [8,67]. Evidence suggests that VEGFR1
may have a functional role of inducing ﬁbroblast migration [68]. The migratory role of VEGFR1 may
explain the low to no VEGFR1s on cocultured HDFs on day 6 and onward, comparing to 24-h time
point, because ﬁbroblast migration in a coculture may slow down after ﬁbroblasts grow conﬂuent after
three days (data not shown). Another study found hypoxia enhance the production of VEGF and
soluble VEGFR1 (sVEGFR1) in oviductal stromal ﬁbroblasts, and suggest that ﬁbroblasts can control
the growth and permeability of the surrounding microvessel by regulating the production of VEGF
and its naturally occurring inhibitor, sVEGFR1 [69]. This antiangiogenic role of VEGFR1 can explain
why VEGFR1 on both cocultured HUVECs and HDFs remained low (<800 VEGFR1 per cell) from
day 6 to day 17. Further study should examine more time points following the HUVEC/HDF mixing,
especially prior to 24 h and between 24 h and 6 days, to gain a more complete understanding of the
migratory and antiangiogenic role of VEGFR1 signaling.
VEGF-A stimulation of VEGFR2 induces endothelial cell proliferation, survival, migration, and
diﬀerentiation resulting in blood vessel formation and sprouting [70]. In line with the critical role
VEGFR2 plays in angiogenesis, we observed relatively high VEGFR2 plasma membrane concentrations
on cocultured HUVECs (4000–8000 VEGFR2 per cell), comparing to monoculture (~3200 VEGFR2
per cell), suggesting cocultured HUVECs are at a more angiogenic state. Furthermore, our mixture
model revealed a make-up of three subpopulations having diﬀerential VEGFR2 plasma membrane
concentrations within the 24-h cocultured HUVECs (Figure 5A), suggesting that HDF–HUVEC coculture
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may have induced EC diﬀerentiating into multiple phenotypes. These results are consistent with
previous reports on relative expression levels of VEGFR2 playing a crucial role in EC diﬀerentiation:
The highest levels of mRNA and protein of VEGFR2 were found in tip cells [60,71]. One study measured
the fold diﬀerence between HUVECs with tip cell phenotype and the ones without, and found VEGFR2
expression is ~5.9-fold higher in tip cells, which aligns with our results of a ~5.5-fold higher VEGFR2
transmembrane protein concentration on 29.6% high-VEGFR2 HUVEC subpopulation than 24.7%
low-VEGFR2 subpopulation (Figure 5A). Future experiments should include further analysis of sorted
high-VEGFR2 HUVECs and their functional characteristics.
We found a 50–150% increase of Tie2 plasma membrane concentration in cocultured HUVEC
on day 17 comparing to previous time points we measured (Figure 2C), suggesting the role of
Tie2 in maintaining mature vasculature and quiescence. Indeed, Ang–Tie signaling pathways are
known to play a role in both promoting angiogenesis and quiescence [72–74]. The expression of
Tie2 protein on EC plasma membrane aligns with previous studies of ECs in vitro [31,32,75,76] and
in vivo [77]. Furthermore, Ang–Tie signaling pathways have been identiﬁed as one of the escaping
mechanisms tumor vasculature develops in response to anti-VEGF treatment, which made Ang–Tie
a novel drug target for antiangiogenesis therapy [78,79]. Using qFlow cytometry, future studies can
quantitatively examine how antiangiogenic drugs like Bevacizumab regulates Tie2 concentrations.
This will give us insights in whether a 2D HUVEC–HDF coculture system can be used as a tool to
study anti-VEGF resistance.
Our ﬁndings of PDGFRβ plasma membrane expression on cocultured HUVECs suggest that
PDGFRβ may be a biomarker for angiogenic ECs in vivo. It is known that ECs secret PDGFs to
recruit perivascular cells like pericytes [56,80], however, the mechanism of how PDGFR deﬁnes ECs
phenotypes is still unclear, given that cultured ECs do not express PDGFR natively [8,32]. One
study showed PDGFRβ proteins on endothelial sprouts (tip-cell-like ECs) but not nonangiogenic ECs
(stalk-cell-like ECs) [61]. This dynamic expression of PDGFRβ on ECs is consistent with our ﬁndings of
a 10% subpopulation of cocultured HUVECs on day 17 with an average of 8800 PDGFRβs per HUVEC,
while the rest of HUVECs having much lower PDGFRβ concentration. Another study showed that
tip cells are distinguished from stalk cells by their strong expression of PDGF-B mRNA and VEGFR2
mRNA and their proteins in an in situ model of early postnatal retina [60]. Our lab and others have
found PDGFR proteins on endothelial-like cells in disease tissues, including glioblastoma (GBM) [7,81],
breast carcinoma [82], and ischemic tissues [83]. Particularly, we found ~3000 plasma membrane
PDGFRβ per cell on endothelial-like cells using a GBM39 patient-derived xenograft model [7], which
is similar to the 2920 PDGFRβ per cell we found on day-6 cocultured HUVECs (Figure 2F). Therefore,
the quantiﬁcation of PDGFRβ will help us identify the angiogenic EC phenotype, which can be used to
evaluate the physiological relevance of the model.
EC heterogeneity, including variations in cell morphology, protein expression, and function, is
a hallmark of vasculatures in vivo [7,84,85]; recent advances in single-cell technologies [32,86–89]
have allowed for characterization of such heterogeneity. To quantify heterogeneity of each cell
population, we used two statistical methods in this study: Quadratic entropy (QE) and BIC-assisted
Gaussian mixture modeling. Interestingly, both cocultured HDFs and HUVECs showed relatively
low heterogeneity determined by a 0.2–0.6 QE, whereas ECs from a GBM xenograft had higher QE
(0.6–1.3) [7], suggesting that our ﬁbroblast–EC coculture may be closer to in vitro monocultures than
in vivo tissue as to cell-to-cell receptor variation. The discrepancy of QE between our coculture model
and GBM tissue could be due to the lack of physical variables like levels of oxygen, ﬂow, pressure, 3D
environment, etc. in the 2D coculture system. Therefore, characterizing EC heterogeneity in coculture
models is necessary to develop in vitro models that are biologically faithful. Alternatively, BIC-assisted
Gaussian mixture model determines the number of mixture components within each cell population,
thus, is a measurement of cell heterogeneity. Generally, one to two mixture components are considered
low heterogeneity [32], while more than two components is considered highly heterogeneous [4,7,9].
In this study, BIC-assisted Gaussian modeling revealed two to three subpopulations among cocultured
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HUVECs with varying concentrations of VEGFR2, NRP1, and PDGFRβ, which was not seen in
monocultures previously, suggesting that introducing HDFs, even in vitro, may have a determining
eﬀect on EC diﬀerentiation, and thus, one step closer to angiogenic ECs in vivo.
5. Conclusions
In summary, we adopted a simple 2D human angiogenesis assay comprised of HUVECs and
HDFs, and examined temporal dynamics of concentrations and heterogeneity of a panel of 6 angiogenic
receptors up to 17 days. Particularly, we optimized and established the seeding conditions so that
HUVECs supported by HDFs form capillary-like structures during the 17 days. Within 24 h coculturing,
we observed ~2700 VEGFR1 per cell on HDFs, which do not natively express VEGFR when cultured
alone. In line with the proangiogenic role of VEGFR2, we observed 20–140% increase in plasma
membrane VEGFR2 concentrations (4000–8100 receptors per cell) on cocultured HUVECs as tubules
develop when compared to monocultures. We observed a ~50% increase in Tie2 concentration on
HUVECs during late-stage tube formation, which aligns with the theory that Ang–Tie2 signaling
mediates quiescence of blood vessels. We showed steady increase of PDGFRs on HDFs; in particular,
PDGFRβs were found on HUVECs during the ﬁrst 6 h of coculturing (1900–2900 PDGFRβs per
cell). These quantitative ﬁndings showcased for the ﬁrst time how EC-stromal contact aﬀects plasma
membrane receptor concentrations when compared to EC monocultures.
A robust, in-vivo-like, quantiﬁable angiogenesis model will not only advance pharmacologic
validation of antiangiogenic drugs, but will also provide accurate parameters to computational models.
Traditional in vitro assays investigating angiogenesis utilize complex protein mixture (e.g., Matrigel)
to induce EC diﬀerentiation and tubule formation; however, the tubules formed in these assays suﬀer
from a lack of heterogeneity and debatable lumens [90,91]. Our coculture assay is technically simple,
reproducible, and inexpensive; coculture models have several advantages, including the incorporation
of stromal cells (e.g., ﬁbroblasts that secrete growth factors and ECM) and heterogeneous cell–cell
contact. One disadvantage of coculture assays is that interactions between ECs and stromal cells are
undeﬁned and the method is less well-characterized [27,90]. Therefore, reliable, quantiﬁed coculture
assays like ours are necessary to study EC–stromal interactions. Another limitation of 2D assays is
the lack of biomechanical forces (e.g., shear stress) present in vivo [24,85,92,93], recent advances in
microﬂuidics have allowed the development of perfused vascular 3D models [94]. Future studies
should extend the single-cell receptor quantiﬁcation to vessels in vivo and other types of preclinical
angiogenesis models to evaluate their physiological relevance.
The VEGFRs and PDGFRs belong to the same RTK class, immunoglobulin (Ig)-like RTKs [53,95].
Ig-like RTKs are equipped with an extracellular ligand-binding domain consists of immunoglobulin
(Ig)-like domains. This RTK class include several important receptors including receptors for ﬁbroblast
growth factor (FGF) [96], which are involved in the regulation of angiogenesis [97]. Therefore,
quantiﬁcation of other RTKs with similar Ig-like extracellular domains will be a good extension of
this study.
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Abbreviation
HUVEC
HDF
VEGF
Ang
PDGF
FGF
NRP
PFA
BSA
FBS
DMEM
EGM
EDTA
HBSS
PE
FITC
DAPI
QE
ECM
GBM
Ig

Human umbilical vein endothelial cell
Human dermal ﬁbroblasts
Vascular endothelial growth factor
Angiopoietin
Platelet-derived growth factor
Fibroblast growth factor
Neuropilin
Paraformaldehyde
Bovine serum albumin
Fetal bovine serum
Dulbecco’s Modiﬁed Eagle Media
Endothelial Growth Media
Ethylenediaminetetraacetic acid
Hank’s Balanced Salt Solution
Phycoerythrin
Fluorescein isothiocyanate
4 ,6-diamidino-2-phenylindole
Quadratic entropy
Extracellular matrix
Glioblastoma
Immunoglobulin
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